Banque Cantonale Vaudoise’s Novavax NVAX Stock Holding History

Banque Cantonale Vaudoise’s Portfolio NVAX Stock Details NVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-3,000	Closed	-$38K	–	936
2024 Q2	$38K	Buy	3,000 +2,500	+500%	+$25.2K	﹤0.01%	832
2024 Q1	$2K	Hold	500	–	–	﹤0.01%	971
2023 Q4	$2K	Hold	500	–	–	﹤0.01%	997
2023 Q3	$4K	Hold	500	–	–	﹤0.01%	1149
2023 Q2	$4K	Hold	500	–	–	﹤0.01%	1140
2023 Q1	$3K	Hold	500	–	–	﹤0.01%	1156
2022 Q4	$5K	Hold	500	–	–	﹤0.01%	1145
2022 Q3	$9K	Hold	500	–	–	﹤0.01%	1156
2022 Q2	$26K	Sell	500 -11,131	-96%	-$577K	﹤0.01%	1096
2022 Q1	$857K	Buy	11,631 +11,258	+3,018%	+$1M	0.04%	425
2021 Q4	$54K	Sell	373 -3,700	-91%	-$636K	﹤0.01%	1057
2021 Q3	$844K	Sell	4,073 -5,877	-59%	-$1.3M	0.04%	438
2021 Q2	$2.11M	Buy	9,950 +9,850	+9,850%	+$1.8M	0.09%	219
2021 Q1	$18K	Buy	+100	New	+$19.9K	﹤0.01%	1085

Other funds holding NVAX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Banque Cantonale Vaudoise's NVAX Position: Q3 2024 in Review

Banque Cantonale Vaudoise sold out of Novavax (NVAX) in Q3 2024, closing a stake of 3,000 shares — an estimated $38K sold.

Banque Cantonale Vaudoise first reported a position in NVAX in Q1 2021 and held it in 14 quarters. The position peaked at $2.11M in Q2 2021. 237 funds tracked by Wall St. Rank hold NVAX as of Q3 2024.

Banque Cantonale Vaudoise reported no remaining Novavax position as of Q3 2024 after selling out during the quarter.
Banque Cantonale Vaudoise sold 3,000 Novavax shares in Q3 2024, an estimated $38K.
Banque Cantonale Vaudoise first reported a position in Novavax in Q1 2021 and held it in 14 quarters.
Banque Cantonale Vaudoise's Novavax position peaked at $2.11M in Q2 2021.
237 funds tracked by Wall St. Rank held Novavax as of Q3 2024.

Based on Banque Cantonale Vaudoise's 13F filing for Q3 2024, filed 8 Nov 2024.